Involvement of nuclear factor-kappa B in bcl-xL-induced interleukin 8 expression in glioblastoma

Journal of Neurochemistry

Volumn 107, Issue 3, 2008, Pages 871-882

  Gabellini, Chiara ^a   Castellini, Laura ^a   Trisciuoglio, Daniela ^a   Kracht, Michael ^b   Zupi, Gabriella ^a   Del Bufalo, Donatella ^a  

^a REGINA ELENA NATIONAL CANCER INSTITUTE   (Italy)

^b JUSTUS LIEBIG UNIVERSITY   (Germany)

Author keywords

Bcl xL; Glioblastoma; Interleukin 8; Nuclear factor kappa B

Indexed keywords

I KAPPA B ALPHA; I KAPPA B KINASE ALPHA; I KAPPA B KINASE BETA; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 8; PROTEIN BCL XL; PROTEIN P50; SYNAPTOTAGMIN I;

ARTICLE; CONTROLLED STUDY; GEL MOBILITY SHIFT ASSAY; GENE EXPRESSION; GENETIC TRANSFECTION; GLIOBLASTOMA; HUMAN; HUMAN CELL; PRIORITY JOURNAL; PROTEIN DNA BINDING; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN PHOSPHORYLATION; PROTEIN PROTEIN INTERACTION; RNA INTERFERENCE; SIGNAL TRANSDUCTION; WESTERN BLOTTING;

BCL-X PROTEIN; BLOTTING, WESTERN; CELL LINE, TUMOR; ELECTROPHORETIC MOBILITY SHIFT ASSAY; ENZYME-LINKED IMMUNOSORBENT ASSAY; GENE EXPRESSION REGULATION; GLIOBLASTOMA; HUMANS; INTERLEUKIN-8; NEOVASCULARIZATION, PATHOLOGIC; NF-KAPPA B; PROMOTER REGIONS, GENETIC; SIGNAL TRANSDUCTION; TRANSFECTION; UP-REGULATION;

EID: 53749105340     PISSN: 00223042     EISSN: 14714159     Source Type: Journal    
DOI: 10.1111/j.1471-4159.2008.05661.x     Document Type: Article

References (56)

1. Adams J. M. Cory S. (2007) The Bcl-2 apoptotic switch in cancer development and therapy. Oncogene 26, 1324 1337.
2. Amundson S. A., Myers T. G., Scudiero D., Kitada S., Reed J. C. Fornace A. J. Jr. (2000) An informatics approach identifying markers of chemosensitivity in human cancer cell lines. Cancer Res. 60, 6101 6110.
3. Badrichani A. Z., Stroka D. M., Bilbao G., Curiel D. T., Bach F. H. Ferran C. (1999) Bcl-2 and Bcl-XL serve an anti-inflammatory function in endothelial cells through inhibition of NF-kappaB. J. Clin. Invest. 103, 543 553.
4. Betts J. C. Nabel G. J. (1996) Differential regulation of NF-kappaB2(p100) processing and control by amino-terminal sequences. Mol. Cell. Biol. 16, 6363 6371.
5. Biroccio A., Candiloro A., Mottolese M., Sapora O., Albini A., Zupi G. Del Bufalo D. (2000) Bcl-2 overexpression and hypoxia synergistically act to modulate vascular endothelial growth factor expression and in vivo angiogenesis in a breast carcinoma line. FASEB J. 14, 652 660.
6. Bivona T. G., Quatela S. E., Bodemann B. O. et al. (2006) PKC regulates a farnesyl-electrostatic switch on k-Ras that promotes its association with BCL-XL on mithocondria and induces apoptosis. Mol. Cell 21, 481 493.
7. Brat D. J., Bellail A. C. Van Meir E. G. (2005) The role of interleukin-8 and its receptors in gliomagenesis and tumoral angiogenesis. Neuro Oncol. 7, 122 133.
8. Brown R. E. Law A. (2006) Morphoproteomic demonstration of constitutive nuclear factor-kappaB activation in glioblastoma multiforme with genomic correlates and therapeutic implications. Ann. Clin. Lab. Sci. 36, 421 426.
9. Charalambous C., Pen L. B., Su Y. S., Milan J., Chen T. C. Hofman F. M. (2005) Interleukin-8 differentially regulates migration of tumor-associated and normal human brain endothelial cells. Cancer Res. 65, 10347 10354.
10. Chen G. G., Liang N. C., Lee J. F., Chan U. P., Wang S. H., Leung B. C. Leung K. L. (2004) Over-expression of Bcl-2 against Pteris semipinnata L-induced apoptosis of human colon cancer cells via a NF-kappa B-related pathway. Apoptosis 9, 619 627.
11. Côme C., Arnoux V., Bibeau F. Savagner P. (2004) Roles of the transcription factors snail and slug during mammary morphogenesis and breast carcinoma progression. J. Mammary Gland Biol. Neoplasia 9, 183 193.
12. Del Bufalo D., Biroccio A., Leonetti C. Zupi G. (1997) Bcl-2 overexpression enhances the metastatic potential of a human breast cancer line. FASEB J. 11, 947 953.
13. Desbaillets I., Diserens A. C., de Tribolet N., Hamou M. F. Van Meir E. G. (1999) Regulation of interleukin-8 expression by reduced oxygen pressure in human glioblastoma. Oncogene 18, 1447 1456.
14. Feng H., Xiang H., Mao Y. W., Liu J. P., Huang X. Q., Liu Y., Liu S. J., Luo C. Zhang X. J. (2004) Human Bcl-2 activates ERK signaling pathway to regulate activating protein-1, lens epithelium-derived growth factor and downstream genes. Oncogene 23, 7310 7321.
15. Fernandez A., Udagawa T., Schwesinger C., Beecken W., Achilles-Gerte E., McDonnell T. D'Amato R. (2001) Angiogenic potential of prostate carcinoma cells overexpressing bcl-2. J. Natl Cancer Inst. 93, 208 213.
16. Gilmore T. D. Herscovitch M. (2006) Inhibitors of NF-kappaB signaling: 785 and counting. Oncogene 25, 6887 6899.
17. Giorgini S., Trisciuoglio D., Gabellini C., Desideri M., Castellini L., Colarossi C., Zangemeister-Wittke U., Zupi G. Del Bufalo D. (2007) Modulation of bcl-xL in tumor cells regulates angiogenesis through CXCL8 expression. Mol. Cancer Res. 5, 761 771.
18. Harant H., de Martin R., Andrew P. J., Foglar E., Dittrich C. Lindley I. J. (1996) Synergistic activation of interleukin-8 gene transcription by all-trans-retinoic acid and Tumor Necrosis Factor-α involves the transcription factor NF-kB. J. Biol. Chem. 271, 26954 26961.
19. Hoffmann E., Dittrich-Breiholz O., Holtmann H. Kracht M. (2002) Multiple control of interleukin-8 gene expression. J. Leukoc. Biol. 72, 847 855.
20. Hoffmann E., Thiefes A., Buhrow D., Dittrich-Breiholz O., Schneider H., Resch K. Kracht M. (2005) MEK1-dependent delayed expression of Fos-related antigen-1 counteracts c-Fos and p65 NF-kappaB-mediated interleukin-8 transcription in response to cytokines or growth factors. J. Biol. Chem. 280, 9706 9718.
21. Holtmann H., Winzen R., Holland P. et al. (1999) Induction of interleukin-8 synthesis integrates effects on transcription and mRNA degradation from at least three different cytokine- or stress-activated signal transduction pathways. Mol. Cell. Biol. 19, 6742 6753.
22. Iervolino A., Trisciuoglio D., Ribatti D., Candiloro A., Biroccio A., Zupi G. Del Bufalo D. (2002) Bcl-2 overexpression in human melanoma cells increases angiogenesis through VEGF mRNA stabilization and HIF-1-mediated transcriptional activity. FASEB J. 16, 1453 1455.
23. Jang J. H. Surh Y. J. (2004) Possible role of NF-kB in Bcl-xL protection against hydrogen peroxide-induced PC12 cell death. Redox Rep. 9, 343 348.
24. Jiang Z. Clemens P. R. (2006) Cellular caspase-8-like inhibitory protein (cFLIP) prevents inhibition of muscle cell differentiation induced by cancer cells. FASEB J. 20, 2570 2572.
25. Jiang B., Xu S., Xiuyun H., Pimentel D. R., Brecher P. Cohen R. A. (2004) Temporal control of NF-kB activation by ERK differentially regulates interleukin-1β-induced gene expression. J. Biol. Chem. 279, 1323 1329.
26. Kaneko T., Zhang Z., Mantellini M. G. et al. (2007) Bcl-2 orchestrates a cross-talk between endothelial and tumor cells that promotes tumor growth. Cancer Res. 67, 9685 9693.
27. Karin M. Ben-Neriah Y. (2000) Phosphorylation meets ubiquitination: the control of NF-[kappa]B activity. Annu. Rev. Immunol. 18, 621 663.
28. Karl E., Warner K., Zeitlin B. et al. (2005) Bcl-2 acts in a proangiogenic signaling pathway through nuclear factor-kappaB and CXC chemokines. Cancer Res. 65, 5063 5069.
29. Karl E., Zhang Z., Dong Z., Neiva K. G., Soengas M. S., Koch A. E., Polverini P. J., Núñez G. Nör J. E. (2007) Unidirectional crosstalk between Bcl-xL and Bcl-2 enhances the angiogenic phenotype of endothelial cells. Cell Death Differ. 14, 1657 1666.
30. Kunsch C. Rosen C. A. (1993) NF-kappa B subunit-specific regulation of the interleukin-8 promoter. Mol. Cell. Biol. 13, 6137 6146.
31. Li J., Moran T., Swanson E., Julian C. et al. (2004) Regulation of IL-8 and IL-1beta expression in Crohn's disease associated NOD2/CARD15 mutations. Hum. Mol. Genet. 13, 1715 1725.
32. Li L., Gondi C. S., Dinh D. H., Olivero W. C., Gujrati M. Rao J. S. (2007) Transfection with anti-p65 intrabody suppresses invasion and angiogenesis in glioma cells by blocking nuclear factor-kappaB transcriptional activity. Clin. Cancer Res. 13, 2178 2190.
33. de Moissac D., Mustapha S., Greenberg A. H. Kirshenbaum L. A. (1998) Bcl-2 activates the transcription factor NFkappaB through the degradation of the cytoplasmic inhibitor IkappaBalpha. J. Biol. Chem. 273, 23946 23951.
34. de Moissac D., Zheng H. Kirshenbaum L. A. (1999) Linkage of the BH4 domain of Bcl-2 and the nuclear factor kappaB signaling pathway for suppression of apoptosis. J. Biol. Chem. 274, 29505 29509.
35. Mukaida N., Shiroo M. Matsushima K. (1989) Genomic structure of the human monocyte-derived neutrophil chemotactic factor IL-8. J. Immunol. 143, 1366 1371.
36. Mukaida N., Okamoto S., Ishikawa Y. Matsushima K. (1994) Molecular mechanism of interleukin-8 gene expression. J. Leukoc. Biol. 56, 554 558.
37. Park C. C., Morel J. C., Amin M. A., Connors M. A., Harlow L. A. Koch A. E. (2001) Evidence of IL-18 as a novel angiogenic mediator. J. Immunol. 167, 1644 1653.
38. Raychaudhuri B., Han Y., Lu T. Vogelbaum M. A. (2007) Aberrant constitutive activation of nuclear factor kappaB in glioblastoma multiforme drives invasive phenotype. J. Neurooncol. 85, 39 47.
39. Regula K. M., Ens K. Kirshenbaum L. A. (2002) IKK beta is required for Bcl-2-mediated NF-kappa B activation in ventricular myocytes. J. Biol. Chem. 277, 38676 38682.
40. Ricca A., Biroccio A., Del Bufalo D., Mackay A. R., Santoni A. Cippitelli M. (2000) Bcl-2 over-expression enhances NF-kappaB activity and induces mmp-9 transcription in human MCF7(ADR) breast-cancer cells. Int. J. Cancer 86, 188 196.
41. Sakurai H., Suzuki S., Kawasaki N., Sakurai H., Suzuki S. Kawasaki N. (2003) Tumor necrosis factor-alpha-induced IKK phosphorylation of NF-kappaB p65 on serine 536 is mediated through the TRAF2, TRAF5, and TAK1 signaling pathway. J. Biol. Chem. 278, 36916 36923.
42. Schmitt E., Beauchemin M. Bertrand R. (2007) Nuclear colocalization and interaction between bcl-xL and cdk1(cdc2) during G2/M cell-cycle checkpoint. Oncogene 26, 5851 5865.
43. Senftleben U., Cao Y., Xiao G. et al. (2001) Activation by IKKalpha of a second, evolutionary conserved, NF-kappa B signaling pathway. Science 293, 1495 1499.
44. Solan N. J., Miyoshi H., Carmona E. M., Bren G. D. Paya C. V. (2002) RelB cellular regulation and transcriptional activity are regulated by p100. J. Biol. Chem. 277, 1405 1418.
45. Sparmann A. Bar-Sagi D. (2004) Ras-induced interleukin-8 expression plays a critical role in tumor growth and angiogenesis. Cancer Cell 6, 447 458.
46. Stein B. Baldwin A. S. Jr. (1993) Distinct mechanisms for regulation of the interleukin-8 gene involve synergism and cooperativity between C/EBP and NF-kappa B. Mol. Cell. Biol. 13, 7191 7198.
47. Trisciuoglio D., Iervolino A., Candiloro A., Fibbi G., Fanciulli M., Zangemeister-Wittke U., Zupi G. Del Bufalo D. (2004) Bcl-2 induction of urokinase plasminogen activator receptor expression in human cancer cells through Sp1 activation: involvement of ERK1/ERK2 activity. J. Biol. Chem. 279, 6737 6745.
48. Trisciuoglio D., Desideri M., Ciuffreda L. et al. (2005a) Bcl-2 overexpression in melanoma cells increases tumor progression-associated properties and in vivo tumor growth. J. Cell. Physiol. 205, 414 421.
49. Trisciuoglio D., Iervolino A., Zupi G. Del Bufalo D. (2005b) Involvement of PI3K and MAPK signaling in bcl-2-induced vascular endothelial growth factor expression in melanoma cells. Mol. Biol. Cell 16, 4153 4162.
50. Wakabayashi K., Kambe F., Cao X., Murakami R., Mitsuyama H., Nagaya T., Saito K., Yoshida J. Seo H. (2004) Inhibitory effects of cyclosporin A on calcium mobilization-dependent interleukin-8 expression and invasive potential of human glioblastoma U251MG cells. Oncogene 23, 6924 6932.
51. Wang H. G., Miyashita T., Takayama S., Sato T., Torigoe T., Krajewski S., Tanaka S., Hovey L. III., Troppmair J. Rapp U. R. (1994) Apoptosis regulation by interaction of Bcl-2 protein and Raf-1 kinase. Oncogene 9, 2751 2756.
52. Weiler M., Bähr O., Hohlweg U. et al. (2006) BCL-xL: time-dependent dissociation between modulation of apoptosis and invasiveness in human malignant glioma cells. Cell Death Differ. 13, 1156 1169.
53. Woronicz J. D., Gao X., Cao Z., Rothe M. Goeddel D. V. (1997) IkappaB kinase-beta: NF-kappaB activation and complex formation with IkappaB kinase-alpha and NIK. Science 278, 866 869.
54. Yao X., Ping Y., Chen J., Chen D., Xu C., Zheng J., Ming Wang J. Bian X. (2008) Production of angiogenic factors by human glioblastoma cells following activation of the G-protein coupled formylpeptide receptor FPR. J. Neurooncol. 86, 47 53.
55. Zarnegar B., Yamazaki S., He J. Q. Cheng G. (2008) Control of canonical NF-{kappa}B activation through the NIK-IKK complex pathway. Proc. Natl Acad. Sci. USA 105, 3503 3508.
56. Zhang C., Carl T. F., Trudeau E. D., Simmet T. Klymkowsky M. W. (2006) An NF-kappaB and slug regulatory loop active in early vertebrate mesoderm. PLoS ONE 1, e106.